148 related articles for article (PubMed ID: 11220758)
21. Biological variability in clinical isolates of Trichomonas vaginalis.
Gómez-Barrio A; Nogal-Ruiz JJ; Montero-Pereira D; Rodríguez-Gallego E; Romero-Fernandez E; Escario JA
Mem Inst Oswaldo Cruz; 2002 Sep; 97(6):893-6. PubMed ID: 12386717
[TBL] [Abstract][Full Text] [Related]
22. Genetic characterization of Trichomonas vaginalis isolates by use of multilocus sequence typing.
Cornelius DC; Robinson DA; Muzny CA; Mena LA; Aanensen DM; Lushbaugh WB; Meade JC
J Clin Microbiol; 2012 Oct; 50(10):3293-300. PubMed ID: 22855512
[TBL] [Abstract][Full Text] [Related]
23. Characterization of trichomonad species and strains by PCR fingerprinting.
Vanácová S; Tachezy J; Kulda J; Flegr J
J Eukaryot Microbiol; 1997; 44(6):545-52. PubMed ID: 9435127
[TBL] [Abstract][Full Text] [Related]
24. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of Conventional Methods with Molecular Methods in the Diagnosis of Trichomonas vaginalis and Investigation of Metronidazole Resistance].
Özel Y; Çavuş İ; Usta A; Vardar Ünlü G; Özbilgin A; Ünlü M
Mikrobiyol Bul; 2023 Oct; 57(4):625-638. PubMed ID: 37885390
[TBL] [Abstract][Full Text] [Related]
26. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.
Rasoloson D; Tomková E; Cammack R; Kulda J; Tachezy J
Parasitology; 2001 Jul; 123(Pt 1):45-56. PubMed ID: 11467782
[TBL] [Abstract][Full Text] [Related]
27. Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis.
Chen MY; Smith NA; Fox EF; Bingham JS; Barlow D
Int J STD AIDS; 1999 Apr; 10(4):277-80. PubMed ID: 12035784
[No Abstract] [Full Text] [Related]
28. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
[TBL] [Abstract][Full Text] [Related]
29. Genetic diversity in Trichomonas vaginalis.
Meade JC; Carlton JM
Sex Transm Infect; 2013 Sep; 89(6):444-8. PubMed ID: 23702460
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Schwebke JR; Barrientes FJ
Antimicrob Agents Chemother; 2006 Dec; 50(12):4209-10. PubMed ID: 17000740
[TBL] [Abstract][Full Text] [Related]
31. Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis.
Conrad MD; Gorman AW; Schillinger JA; Fiori PL; Arroyo R; Malla N; Dubey ML; Gonzalez J; Blank S; Secor WE; Carlton JM
PLoS Negl Trop Dis; 2012; 6(3):e1573. PubMed ID: 22479659
[TBL] [Abstract][Full Text] [Related]
32. Genetic variance of Trichomonas vaginalis isolates by Southern hybridization.
Ryu JS; Min DY; Shin MH; Cho YH
Korean J Parasitol; 1998 Sep; 36(3):207-11. PubMed ID: 9755593
[TBL] [Abstract][Full Text] [Related]
33. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
[TBL] [Abstract][Full Text] [Related]
34. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
[TBL] [Abstract][Full Text] [Related]
35. Activities of dicationic compounds against Trichomonas vaginalis.
Crowell AL; Stephens CE; Kumar A; Boykin DW; Secor WE
Antimicrob Agents Chemother; 2004 Sep; 48(9):3602-5. PubMed ID: 15328138
[TBL] [Abstract][Full Text] [Related]
36. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
37. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
Mammen-Tobin A; Wilson JD
Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
[TBL] [Abstract][Full Text] [Related]
38. Trichomoniasis and its treatment.
Nanda N; Michel RG; Kurdgelashvili G; Wendel KA
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):125-35. PubMed ID: 16441214
[TBL] [Abstract][Full Text] [Related]
39. Population structure and genetic diversity of the parasite Trichomonas vaginalis in Bristol, UK.
Hawksworth J; Levy M; Smale C; Cheung D; Whittle A; Longhurst D; Muir P; Gibson W
Infect Genet Evol; 2015 Aug; 34():36-43. PubMed ID: 26051885
[TBL] [Abstract][Full Text] [Related]
40. Use of Internal Transcribed Spacer Sequence Polymorphisms as a Method for Trichomonas vaginalis Genotyping.
Ertabaklar H; Ertuğ S; Çalışkan SÖ; Malatyalı E; Bozdoğan B
Turkiye Parazitol Derg; 2018 Mar; 42(1):6-10. PubMed ID: 29780013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
